Day One Biopharmaceuticals ( NASDAQ:DAWN – Get Rating ) posted its earnings results on Monday. The company reported ($0.59) earnings per share for the quarter, meeting the consensus estimate of ($0.59), MarketWatch Earnings reports. Day One Biopharmaceuticals Price Performance Shares of Day One Biopharmaceuticals stock traded down $0.10 during trading on Wednesday, hitting $13.88. The stock had a trading volume of 59,809 shares, compared to its average volume of 744,176. The firm's fifty day simple moving average is $15.

https://www.dailypolitical.com/2023/05/03/day-one-biopharmaceuticals-nasdaqdawn-announces-quarterly-earnings-results-hits-estimates.html

#dailypolitical